Claims for Patent: 4,338,325
✉ Email this page to a colleague
Summary for Patent: 4,338,325
Title: | PGI.sub.2 Pharmacologically acceptable salts |
Abstract: | The present invention relates to PGI.sub.2 pharmacologically acceptable salts, having pharmacological activity. Particularly, the compounds described herein are useful as platelet aggregation inhibitors. |
Inventor(s): | Johnson; Roy A. (Kalamazoo, MI), Lincoln; Frank H. (Portage, MI), Pike; John E. (Kalamazoo, MI) |
Assignee: | The Upjohn Company (Kalamazoo, MI) |
Application Number: | 06/200,690 |
Patent Claims: |
1. A composition of matter consisting essentially of a pharmacologically acceptable salt of a compound of formula I ##STR3##
2. A composition according to claim 1 wherein said pharmacologically acceptable salt is the benzyltrimethylammonium salt. 3. A composition according to claim 1 wherein said pharmacologically acceptable salt is the tetramethylammonium salt. 4. A composition according to claim 1 wherein said pharmacologically acceptable salt is the sodium salt. 5. A composition according to claim 4 in a free flowing powder form. 6. A parenteral pharmaceutical composition for inhibition of platelet aggregation characterized in being prepared from (1) a free flowing powder form of the sodium salt of PGI.sub.2, a compound of formula I ##STR4## and (2) a conventional pharmaceutical diluent for parenteral formulations, such that the sodium salt of PGI.sub.2 is present in said composition at a concentration sufficient to inhibit platelet aggregation upon administration of a said composition in a predetermined volume or at a predetermined rate. |